<DOC>
	<DOCNO>NCT02298062</DOCNO>
	<brief_summary>The objective study investigate effect infliximab child n't respond first dose intravenous immunoglobulin ( IVIG ) ( 2g/kg ) Kawasaki disease .</brief_summary>
	<brief_title>Infliximab Kawasaki Disease Patients Resistant IVIG : Multicentre , Prospective , Randomised Trial</brief_title>
	<detailed_description>Kawasaki disease ( KD ) , common cause acquire heart disease develop country , self-limited vasculitis treat high dos intravenous immunoglobulin . Resistance intravenous immunoglobulin Kawasaki disease define temperature 38.0°C high 36 hour 7 day completion infusion intravenous immunoglobulin increase risk coronary artery lesion . We conduct multicenter , randomize , prospective trial determine whether use infliximab child n't respond first dose IVIG ( 2g/kg ) reduces risk coronary artery disease . The IVIG-resistant child randomly assign either infliximab IVIG group 1:1 ratio receive either infliximab ( 5 mg/kg 1 mg/mL intravenously 2 h ) IVIG ( 2g/kg ) . The level leukocyte ( WBC ) count , C-reactive protein , alanine transaminase , interleukin- 1 ( IL-1 ) , interleukin- 6 ( IL-6 ) , tumor necrosis factor-a ( TNF-a ) , soluble tumor necrosis factor receptor-1 ( STNFR-I ) , soluble tumor necrosis factor receptor-2 ( STNFR-2 ) , fever day , cost hospital stay analyze two groups.The final outcome incidence coronary artery lesion .</detailed_description>
	<mesh_term>Mucocutaneous Lymph Node Syndrome</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>( 1 ) Individual patient 's medical file data confirm diagnosis KD use 5th revised edition diagnostic criterion KD , issue Japan Kawasaki Disease Research Committee 7th International Kawasaki Disease Symposium 2002 . ( 2 ) Resistance intravenous immunoglobulin Kawasaki disease define temperature 38.0°C high 36 hour 7 day completion routine primary treatment . ( 3 ) patient age 2 month 12 year old . ( 4 ) All include patient require sign inform consent form . Exclusion criterion : ( 1 ) The patient severe infection ; ( 2 ) The patient history tuberculosis recent close contact tuberculosis ; ( 3 ) The patient vaccinate live vaccine 6 month ; ( 4 ) The patient application hormone immunosuppressive agent ; ( 5 ) The patient '' want sign informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Kawasaki disease coronary artery lesion , IVIG- resistant , Infliximab</keyword>
</DOC>